H.B. Fuller Board Unanimously Rejects Ancora's $1.1B-$1.2B BAS Proposal
FUL sits 21% above its 52-week low of $48.71.
Summary
H.B. Fuller's board unanimously rejected Ancora's unsolicited, non-binding proposal to acquire its Building Adhesive Solutions (BAS) segment, calling the $1.1B-$1.2B valuation 'significantly undervalued.' The board cited BAS's 6% organic growth and 10% EBITDA improvement in Q2, expected earnings contribution from data center buildout, and significant dis-synergies from carving out a business sharing manufacturing across 30+ plants. This follows Ancora's formalized interest on August 12 and comes as H.B. Fuller integrates the Advanced Medical Solutions acquisition. The rejection signals management's confidence in BAS's standalone value and may invite a higher bid or proxy fight from Ancora.
At the time of this announcement, FUL was trading at $58.70 on NYSE in the Manufacturing sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $48.71 to $68.63. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.